4005.T Sumitomo Chemical JPX JPY 506.50 Feb 2026: Volume spike signals earnings

The 4005.T stock (Sumitomo Chemical Company, Limited) closed at JPY 506.50 on JPX in Feb 2026 after a sudden trading surge that pushed volume to 50,133,700 shares, roughly 5.59x the average. The jump followed Q3 FY2025 results and slide deck commentary showing stronger margins in pharmaceuticals and semiconductor materials, which traders cited as the catalyst. We unpack price action, valuation, liquidity and what the surge means for short-term momentum and longer-term outlook.

Market action and liquidity: 4005.T stock most active on JPX

Sumitomo Chemical (4005.T) recorded volume of 50,133,700 versus an average volume of 10,395,703, a clear liquidity event that placed it among the most active Japanese issues on the session. The intraday range touched JPY 458.30 low and JPY 506.80 high, with a close at JPY 506.50. High relative volume suggests institutional participation and re-pricing after the earnings slide deck and transcript were released source.

Earnings and news impact: 4005.T stock reaction to Q3 updates

Q3 FY2025 commentary showed an EPS surprise and profit strength in pharmaceuticals and semiconductor materials, lifting trader sentiment and triggering the volume spike. The company reports EPS of 51.81 and a reported PE of 10.55, metrics that helped frame the move as earnings-driven rather than purely technical. Investors should read the Q3 slides and transcript to match segment commentary with price moves source.

Valuation and fundamentals: 4005.T stock metrics

Sumitomo Chemical trades at a market cap of JPY 895,326,330,000.00 with a trailing PE around 10.55 and dividend per share of JPY 12.00 (yield ~2.19%). Key ratios include price/book 0.87, price/sales 0.37, and free cash flow yield near 10.38%. Debt-to-equity sits at 1.19, and interest coverage is 2.18. These figures underline value-style characteristics but with leverage that requires monitoring.

Technical picture and trading signals: 4005.T stock technicals

Technical indicators show mixed momentum: RSI 54.17 and CCI 160.47 (short-term overbought), MACD histogram turning positive. The 50-day average is JPY 462.86 and the 200-day average is JPY 415.30, supporting a bullish medium-term bias. Volatility rose; ATR is 9.25. With relative volume at 5.59x, trade execution costs and short-term volatility risk are elevated despite constructive moving averages.

Meyka AI grade and forecast: 4005.T stock evaluation

Meyka AI rates 4005.T with a score out of 100: 72.93 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of JPY 490.54 and a yearly price of JPY 287.76, implying a -3.15% downside vs current price for the month and -43.19% over 12 months. Forecasts are model-based projections and not guarantees. The grade reflects strong cash flow yields and reasonable valuation, offset by leverage and segment cyclicality.

Outlook and price targets: 4005.T stock short-term strategy

Analyst consensus is limited publicly, so we frame price targets from valuation and momentum. A near-term price target of JPY 540.00 (upside 6.62%) reflects segment re-rating if semiconductor and pharma momentum continues. A conservative 12-month target of JPY 480.00 (downside -5.22%) assumes mean reversion and sector headwinds. Position sizing should reflect higher intraday volatility after the volume spike.

Final Thoughts

4005.T stock moved into the most-active list on JPX after Q3 commentary drove a volume surge and a close at JPY 506.50. Fundamentals show value characteristics—PE 10.55, price/book 0.87, free cash flow yield near 10.38%—but leverage (debt/equity 1.19) and cyclical segment exposure are risk factors. Meyka AI rates the stock 72.93/100 (B+, BUY) while noting model projections include a monthly forecast of JPY 490.54, implying -3.15% versus current price; longer-term projections show larger downside, so horizon matters. For most-active traders, focus on execution given 50,133,700 shares traded and elevated volatility. Long-term investors should weigh cash-flow strength and dividend yield against debt and sector cyclicality. Meyka AI provides this analysis as an AI-powered market analysis platform; forecasts are model outputs and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.